IBKS No.25 Special Purpose Acquisition

0099X0 · KOSDAQ · ₩0099X0 · IBKS제25호스팩

₩2,070▼ ₩20 (0.96%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

What brokers say about IBKS No.25 Special Purpose Acquisition

No public broker reports on this company yet.

Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.

AI summary of public information

An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.

IBKS No.25 is a shell SPAC with no revenue, a stock down sharply from its 52-week high, and a pending merger decision in its filings.

IBKS No.25 Special Purpose Acquisition is a KOSDAQ-listed blank-check company whose only purpose is to merge with a private or listed company. It reported no revenue and small losses for 2025 and the half-year to H1 2026, with about ₩2.3B in cash and ₩1.3B in borrowings. Its shares closed at ₩2,090 on 2026-10-29, roughly 70% below the 52-week high, for a market cap of about ₩12.5B.

What stands out

  • Revenue was zero in 2025 and in the trailing period to H1 2026, and operating loss was about ₩26M, so the company has no operating business to judge.
  • The profile says it is not negotiating with or evaluating any specific target, yet recent filings include a merger decision, amended merger decisions, and a shareholders' meeting called, which the data does not explain.
  • The share price fell 4.6% over one month and 9.1% over three months, and sits near its 52-week low of ₩2,030.
  • Price-to-book is about 1.1, and the data gives no P/E or P/S because there are no earnings or sales.
  • Foreign ownership is 0.2%, and over the last 20 days institutions were net sellers of about ₩1.2B while retail investors were net buyers of about ₩1.2B.

What to watch

  • The contents of the merger decision and the shareholders' meeting, since the data does not say which company, if any, is the merger counterparty.
  • Further amended filings, given that several merger-related documents were amended in October 2026.
  • Whether the company's cash and borrowings change as the merger process proceeds, and the next quarterly report.

Data as of Oct 29, 2026 · written 2d ago

This is not financial advice.

Also known as: IBKS No.25 Special Purpose Acquisition / IBKS제25호스팩 / 0099X0 / KRX:0099X0

Source: KRX statistical information